Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

ezetimibe-atorvaSTATin

ezetimibe-atorvaSTATin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Liptruzet TABLET, ORAL 10 mg-10 mg, 10 mg-20 mg, 10 mg-40 mg, 10 mg-80 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

ezetimibe-atorvaSTATin (Liptruzet)

  • 10 mg-10 mg tablet                                                              
  • 10 mg-20 mg tablet                                                               
  • 10 mg-40 mg tablet                                                               
  • 10 mg-80 mg tablet

ezetimibe (Zetia) AND atorvaSTATin (Lipitor)

  • ONE 10 mg ezetimibe tablet PLUS ONE 10 mg atorvaSTATin
  • ONE 10 mg ezetimibe tablet PLUS ONE 20 mg atorvaSTATin
  • ONE 10 mg ezetimibe tablet PLUS ONE 40 mg atorvaSTATin
  • ONE 10 mg ezetimibe tablet PLUS ONE 80 mg atorvaSTATin

Reviewed: August 27, 2013 (Liptruzet)

Last updated: Jul. 9, 2021






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved